Intercept Pharmaceuticals

Listing Websites about Intercept Pharmaceuticals

Filter Type:

Homepage - Intercept Pharmaceuticals

(2 days ago) Intercept provides this link as a service to its website visitors. Intercept is not responsible for the content or the privacy policy of any third party websites. Close this window to return to Intercept Pharmaceuticals’ site or click ‘Continue’ to proceed. Continue

Interceptpharma.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals, Inc. (ICPT) Stock Price, News

(6 days ago) Intercept Pharmaceuticals, Inc. Analyst Report: Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


ICPT Stock Price Intercept Pharmaceuticals Inc. Stock

(8 days ago) Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development and commercialization of novel therapeutics in treating chronic liver diseases.

Marketwatch.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals (ICPT) Stock Price, News & Info

(9 days ago) Intercept's stock is ridiculously cheap after last month's sharp pullback. Here's Why Intercept Pharmaceuticals Stock Rose 48.9% in November. Cory Renauer …

Fool.com

Category:  Pharmaceutical Detail Drugs


ICPT Intercept Pharmaceuticals, Inc. — Stock Price and

(4 days ago) Intercept Pharmaceuticals, Inc. NASDAQ Updated Jan 14, 2022 10:11 PM ICPT 17.76 1.31 (7.96%). Post-Market 0.00 (0.00%)

Stocktwits.com

Category:  Pharmaceutical Detail Drugs


INTERCEPT PHARMACEUTICALS, INC. : ICPT Stock Price

(8 days ago) Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat progressive non-viral liver diseases with unmet medical need utilizing its bile acid chemistry.

Marketscreener.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals, Inc. (ICPT) Stock Price Today

(6 days ago) Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals LinkedIn

(8 days ago) Intercept Pharmaceuticals Pharmaceutical Manufacturing New York, NY 47,929 followers Our mission is to build a healthier tomorrow for patients with progressive non-viral liver diseases.

Linkedin.com

Category:  Pharmaceutical,  Health Detail Drugs


Reason’s why Intercept Pharmaceuticals Inc. (ICPT) is an

(7 days ago) Intercept Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $18.12 on 01/19/22, with the lowest value was $14.45 for the same time period, recorded on 01/10/22.

Investchronicle.com

Category:  Pharmaceutical Detail Drugs


Job Postings - Intercept Pharmaceuticals

(Just Now) Intercept is a biopharmaceutical company working to make a difference in the lives of people with progressive non-viral liver diseases. If you are solutions-focused, strive for excellence and want to make an incredible impact on the lives of people living with non-viral liver diseases, view our available career opportunities below.

Interceptpharma.submit4jobs.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals - Wikipedia

(5 days ago) Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal …

En.wikipedia.org

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals, Inc. Common Stock (ICPT) Stock

(Just Now) Intercept Pharmaceuticals, Inc. Common Stock (ICPT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Nasdaq.com

Category:  Pharmaceutical Detail Drugs


Why Intercept Pharmaceuticals Stock Shed 19% of Its Value

(3 days ago) Shares of the small-cap biotech Intercept Pharmaceuticals (NASDAQ:ICPT) sank by a noteworthy 19% during the first six months of 2021, according to data from S&P Global Market Intelligence. The

Fool.com

Category:  Pharmaceutical Detail Drugs


Working at Intercept Pharmaceuticals Glassdoor

(3 days ago) Glassdoor gives you an inside look at what it's like to work at Intercept Pharmaceuticals, including salaries, reviews, office photos, and more. This is the Intercept Pharmaceuticals company profile. All content is posted anonymously by employees working at Intercept Pharmaceuticals.

Glassdoor.com

Category:  Pharmaceutical Detail Drugs


What is Intercept Pharmaceuticals (NASDAQ:ICPT) Sine Of

(3 days ago) Intercept Pharmaceuticals Math Transform with Sine Of Price Series analysis. Intercept Pharmaceuticals Sine Of Price Series

Macroaxis.com

Category:  Pharmaceutical Detail Drugs


ICPT Intercept Pharmaceuticals Inc. Stock Overview (U.S

(7 days ago) Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development and commercialization …

Barrons.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Company Profile - Office

(2 days ago) Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing …

Craft.co

Category:  Pharmaceutical Detail Drugs


ICPT Intercept Pharmaceuticals Inc. Profile MarketWatch

(4 days ago) Intercept Pharmaceuticals Inc. 10 Hudson Yards. 37th floor. New York, New York 10001. Phone 1 646 747-1000. Industry Biotechnology. Sector Health Care/Life Sciences.

Marketwatch.com

Category:  Pharmaceutical,  Health Detail Drugs


Intercept Pharmaceuticals: Regulatory Challenges Offset

(3 days ago) Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT) is in the news once again. This time, an article alleges OCA, the company's only commercialized drug, has become the subject of an FDA investigation

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals (ICPT) May Report Negative

(Just Now) The market expects Intercept Pharmaceuticals (ICPT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2021. This widely-known

Nasdaq.com

Category:  Pharmaceutical Detail Drugs


ICPT Stock Forecast, Price & News (Intercept Pharmaceuticals)

(6 days ago) Intercept Pharmaceuticals' stock was trading at $77.60 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ICPT shares have decreased by 81.5% and is now trading at $14.36. View which stocks have been most impacted by COVID-19.

Marketbeat.com

Category:  Pharmaceutical,  Health Detail Drugs


Intercept Pharmaceuticals Announces Convertible Notes

(Just Now) Intercept Pharmaceuticals Announces Convertible Notes Repurchase. NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (“Intercept”), a biopharmaceutical

Globenewswire.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Employee Reviews Glassdoor

(9 days ago) Pros. " Intercept Pharmaceuticals is an amazing company " (in 4 reviews) " Company with mostly hard-working folks " (in 3 reviews) Cons. " Intercept Company don’t keep talking and keep sending emails about equality and other morals when you don’t have any intention of sticking to it " (in 5 reviews) " Small biotech that wants to operate as

Glassdoor.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals (NasdaqGS:ICPT) - Share price

(3 days ago) Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Pomerantz LLP announced that a class action lawsuit has been filed against Intercept

Simplywall.st

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals, Inc. (ICPT) Stock Forum

(6 days ago) Find the latest Intercept Pharmaceuticals, Inc. (ICPT) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


INTERCEPT PHARMACEUTICALS AKTIE News Aktienkurs

(3 days ago) Intercept Pharmaceuticals Chart. Der Dividenden-Chartvergleich zeigt die Rendite inklusive der Ausschüttungen (Aktienkurs + Dividende, grün) im Vergleich zum Aktienkurs (blau) und so die

Finanzen.net

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Stock Forecast: down to 0

(3 days ago) Intercept Pharmaceuticals Inc () Stock Market info Recommendations: Buy or sell Intercept Pharmaceuticals stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Intercept Pharmaceuticals share forecasts, stock quote and buy / sell signals below.According to present data Intercept Pharmaceuticals's ICPT shares and potentially its …

Walletinvestor.com

Category:  Pharmaceutical Detail Drugs


Stock Alert: Intercept Pharmaceuticals Down 40% Markets

(4 days ago) (RTTNews) - Shares of Intercept Pharmaceuticals, Inc. (ICPT) are losing nearly 40% on Monday morning after the U.S. Food and Drug Administration declined to approve the drug maker's treatment for

Markets.businessinsider.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals, Inc. (ICPT) Stock Price, News

(Just Now) NEW YORK, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that it has formally notified the European Medicines Agency (EMA) of its decision …

Ca.finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Inc. (ICPT): Odds are Looking

(8 days ago) Intercept Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $38.94 on 01/27/21, with the lowest value was $11.60 for the same time period, recorded on 08/20/21.

Investchronicle.com

Category:  Pharmaceutical Detail Drugs


OCALIVA® (obeticholic acid) – Official Patient Website

(4 days ago) I agree to receive information from Intercept Pharmaceuticals about the diseases it treats and its products and services. I understand that my information may be used by Intercept, and companies working with Intercept, for marketing purposes; to conduct market research; and to develop future products, services and programs.

Ocaliva.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Short Interest Ratio and Short

(1 days ago) Intercept Pharmaceuticals' stock is trading up $1.31 today. To short Intercept Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Intercept Pharmaceuticals will decline in price.

Marketbeat.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Inc (ICPT) Quote - XNAS

(Just Now) Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the

Morningstar.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Announces Leadership Transition

(9 days ago) Intercept Pharmaceuticals Announces Leadership Transition. NEW YORK, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the

Globenewswire.com

Category:  Pharmaceutical Detail Drugs


Pomerantz Law Firm Announces the Filing of a Class Action

(8 days ago) NEW YORK, Jan. 6, 2022 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Intercept Pharmaceuticals, Inc. ("Intercept" or the "Company") (NASDAQ: ICPT) and

Prnewswire.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals Revenue 2011-2021 ICPT

(Just Now) Intercept Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat chronic liver disease. The company's lead product candidate, obeticholic acid, or OCA, is a bile acid analog and first-in-class agonist of the farnesoid X receptor (FXR).

Macrotrends.net

Category:  Pharmaceutical Detail Drugs


All News for ICPT : Intercept Pharmaceuticals - Zacks.com

(Just Now) Intercept Pharmaceuticals (ICPT) Reports Q2 Loss, Tops Revenue Estimates. by Zacks Equity Research Published on July 29,2021. Intercept (ICPT) delivered earnings and revenue surprises of 73.39%

Zacks.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals sell Lokrim

(9 days ago) Intercept Pharmaceuticals sell Lokrim. Intercept Pharmaceuticals. Start price €13.26. 09.01.22 / 20%. Target price -09.01.23. Performance (%) 10.11%. Price €14.60. 12.01.22. Summary This prediction is currently active. The prediction currently has a disappointing performance of 10.11%.

Sharewise.com

Category:  Pharmaceutical Detail Drugs


Intercept Stock Off - FDA Declines to Clear Liver-Disease

(1 days ago) Intercept Pharmaceuticals ( ICPT) - Get Intercept Pharmaceuticals, Inc. Report shares on Monday tumbled after the U.S. Food and Drug Administration declined to clear for marketing the drug

Thestreet.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals - ICPT - Stock Price Today - Zacks

(2 days ago) Company Summary. New York, NY-based Intercept Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing novel therapeutics to treat chronic liver diseases to market. The company’s

Zacks.com

Category:  Pharmaceutical Detail Drugs


ICPT: Intercept Pharmaceuticals Inc - Stock Price, Quote

(2 days ago) Intercept Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat progressive non-viral liver diseases with

Cnbc.com

Category:  Pharmaceutical Detail Drugs


Intercept Pharmaceuticals to Reduce Its Workforce by 25%

(3 days ago) Intercept Pharmaceuticals - Get Intercept Pharmaceuticals, Inc. Report announced it would cut its total workforce by 25%, firing a total of 170 employees to reduce its operating expenses. The new

Thestreet.com

Category:  Pharmaceutical Detail Drugs


Product - Intercept Pharmaceuticals Medical Information

(1 days ago) Product. See below for a list of countries where our medication is approved/authorized, as well as links to the product information specific to each country, where applicable.*. Product information is for informational purposes only and not intended as promotion.

Interceptmedinfo.com

Category:  Health Detail Drugs


Ocaliva, Intercept Pharmaceuticals FiercePharma

(6 days ago) Company: Intercept Pharmaceuticals. First approval: May 2016, U.S. FDA. Indication: Primary biliary cholangitis. Past sales estimate: Up to $8.6 billion. 2020 sales: $313 million. Unlike many of

Fiercepharma.com

Category:  Pharmaceutical Detail Drugs

Filter Type:


Popular Searched

 › Random drug testing california law when allowed

 › Degree in medical coding online

 › Urgent care boulevard west hartford

 › Eckerd drug store website

 › Trinity health share provider number

 › Medicare mail order supplier directory

 › Marias healthcare services inc

 › Failing first probation drug test

 › Accountable care coalition of georgia

 › Sw ms regional medical center mccomb ms

Recently Searched

 › Health & wellness products catalog

 › Skokie hospital ambulatory care center

 › Anthem healthkeepers provider portal

 › Kaiser vallejo discharge pharmacy

 › Native american medicine history

 › Christian holistic doctors near me

 › Wellcare authorization form ny

 › Great lakes pharmacy midland

 › Wellcare formulary drug list wv 2022

 › Pharmacy billing and reimbursement

FAQ about Intercept Pharmaceuticals

Who is the CEO of Intercept Pharmaceuticals?

NEW YORK , June 15, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso , President and Chief

What does interintercept pharmaceuticals do?

Intercept Pharmaceuticals Inc. Intercept Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases.

Should I trade Intercept Pharmaceuticals Inc (ICPT) stock?

"Should I trade "ICPT" stock today?" According to our live Forecast System, Intercept Pharmaceuticals Inc stock is a bad long-term (1-year) investment*. "ICPT" stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis.

What are analysts' price targets for Intercept Pharmaceuticals ( intercept) stock?

18 Wall Street analysts have issued 12 month price objectives for Intercept Pharmaceuticals' stock. Their forecasts range from $10.00 to $67.00. On average, they expect Intercept Pharmaceuticals' stock price to reach $33.00 in the next twelve months.